Chun-Qiu Hao

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

Huijie Bian, Zhaohui Zheng, Wei Ding et al. · 2020 · 170 citations · Full text

Immunodeficiencies, Immunology, Host Cell Invasion +19

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

Huijie Bian, Zhaohui Zheng, Wei Ding et al. · Signal Transduction and Targeted Therapy · 2021 · 65 citations · Full text

Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo

Chun-Qiu Hao, Yu-Mei Xie, Meijuan Peng et al. · Clinical and Experimental Medicine · 2013 · 49 citations

Fibrosis, Liver Fibrosis, Hepatology +11

Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C

Chun-Qiu Hao, Yun Zhou, Yu He et al. · Immunology · 2014 · 35 citations · Full text

Clinical Immunology, Type 17, Immunodeficiencies +27

Notch Signaling Contributes to Liver Inflammation by Regulation of Interleukin-22-Producing Cells in Hepatitis B Virus Infection

Wei Xin, Jiuping Wang, Chun-Qiu Hao et al. · Frontiers in Cellular and Infection Microbiology · 2016 · 33 citations · Full text